The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC).
 
Daniel Vargas Pivato de Almeida
Travel, Accommodations, Expenses - Pfizer
 
Justine Anderson
No Relationships to Disclose
 
Daniel Costin Danila
Honoraria - Angle; AxImmune; Bayer; Janssen Oncology; Pfizer; ScreenCell
Consulting or Advisory Role - Angle; AxImmune; Bayer; Pfizer; Sanador
Research Funding - Genentech; Janssen Research & Development (Inst); Prostate Cancer Foundation
Patents, Royalties, Other Intellectual Property - GENE EXPRESSION PROFILE ASSOCIATED WITH PROSTATE CANCER
Travel, Accommodations, Expenses - American Austrian Open Medical Institute; Angle; Bayer; Cambridge Healthtech Institute; Prostate Cancer Foundation; ScreenCell; Stop Cancer
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; ORIC Pharmaceuticals; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte
 
Susan F. Slovin
Consulting or Advisory Role - Bayer; Clovis Oncology; Pfizer
Speakers' Bureau - OncLive; PER; Prime Oncology; Society for Immunotherapy of Cancer
Research Funding - AstraZeneca
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology; Daiichi Sankyo; Janssen; MORE Health; ORIC Pharmaceuticals
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; GlaxoSmithKline; ORIC Pharmaceuticals
 
Erica Simone Dayan
No Relationships to Disclose
 
Tracy Curley
Speakers' Bureau - Bayer
 
Gabrielle Arauz
No Relationships to Disclose
 
Raymond E Baser
No Relationships to Disclose
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Stock and Other Ownership Interests - Asterias Biotherapeutics
Honoraria - Research to Practice
Consulting or Advisory Role - Ambry Genetics/Konica Minolta; Amgen; Bayer; ESSA; Janssen; Janssen Research & Development; Menarini Silicon Biosystems; Sanofi; WIRB-Copernicus Group
Research Funding - Epic Sciences (Inst); Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst); Menarini Silicon Biosystems (Inst); Thermofisher Scientific Biomarkers (Inst)
Travel, Accommodations, Expenses - Amgen; Asterias Biotherapeutics; Bayer; ESSA; Konica Minolta; Menarini Silicon Biosystems; Phosplatin Therapeutics; Prostate Cancer Foundation; Sanofi; WIRB-Copernicus Group
 
Karen A. Autio
Research Funding - Amgen (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); CytomX Therapeutics (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst); Tizona Therapeutics, Inc. (Inst)